Most just lately, it's been discovered that conolidine and the above derivatives act about the atypical chemokine receptor 3 (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds to a wide array of endogenous opioids. Not like most opioid receptors, this receptor acts like a scavenger https://georgew197tvw8.wikiadvocate.com/user